Thyro-Tab.075 mg.
Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.
Cause type: Wrong potency / content
Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.
Thyro-Tab 0.050mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.
Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.
Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.
Subpotent; bupivacaine
Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.
Superpotent (Multiple Ingredient) Drug: Complaint received of oversized tablets.
Superpotent (Single Ingredient Drug): salicylic acid
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.